Cite
Low-molecular-weight oyster peptides ameliorate cyclophosphamide-chemotherapy side-effects in Lewis lung cancer mice by mitigating gut microbiota dysbiosis and immunosuppression.
MLA
Li, Jinzhen, et al. “Low-Molecular-Weight Oyster Peptides Ameliorate Cyclophosphamide-Chemotherapy Side-Effects in Lewis Lung Cancer Mice by Mitigating Gut Microbiota Dysbiosis and Immunosuppression.” Journal of Functional Foods, vol. 95, Aug. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.jff.2022.105196.
APA
Li, J., Yang, L., Li, G., Liu, S., Cao, W., Lin, H., Chen, Z., Qin, X., Huang, J., & Zheng, H. (2022). Low-molecular-weight oyster peptides ameliorate cyclophosphamide-chemotherapy side-effects in Lewis lung cancer mice by mitigating gut microbiota dysbiosis and immunosuppression. Journal of Functional Foods, 95, N.PAG. https://doi.org/10.1016/j.jff.2022.105196
Chicago
Li, Jinzhen, Li Yang, Guiyan Li, Shiying Liu, Wenhong Cao, Haisheng Lin, Zhongqin Chen, Xiaoming Qin, Jinzhi Huang, and Huina Zheng. 2022. “Low-Molecular-Weight Oyster Peptides Ameliorate Cyclophosphamide-Chemotherapy Side-Effects in Lewis Lung Cancer Mice by Mitigating Gut Microbiota Dysbiosis and Immunosuppression.” Journal of Functional Foods 95 (August): N.PAG. doi:10.1016/j.jff.2022.105196.